Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
52,666,446
-
Shares change
-
+693,806
-
Total reported value, excl. options
-
$689,938,271
-
Value change
-
+$4,719,852
-
Put/Call ratio
-
37.8%
-
Number of buys
-
46
-
Number of sells
-
-37
-
Price
-
$13.10
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q4 2016
116 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q4 2016.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52,666,446 shares
of 183,255,226 outstanding shares and own 28.7% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (7,685,568 shares), TANG CAPITAL MANAGEMENT LLC (6,197,198 shares), FMR LLC (5,872,839 shares), JANUS CAPITAL MANAGEMENT LLC (4,575,807 shares), Broadfin Capital, LLC (3,899,587 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (2,813,161 shares), Partner Fund Management, L.P. (2,733,277 shares), BAKER BROS. ADVISORS LP (2,383,569 shares), Cormorant Asset Management, LLC (1,951,263 shares), and HIGHLAND CAPITAL MANAGEMENT LP (1,562,817 shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.